Clinical Trial

A Study to Evaluate the PK Similarity of AK104 in Healthy Chinese Male Participations

Name: A Study to Evaluate the PK Similarity of AK104 in Healthy Chinese Male Participations — clinical trial record (NCT07619001)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study is to evaluate the pharmacokinetic (PK) similarity of AK104 (an anti-PD-1/CTLA-4 bispecific antibody) from the proposed new manufacturing site and the approved original site in healthy male participants.

Trial Details

NCT Number	NCT07619001
Lead Sponsor	Akeso
Conditions	Healthy Male Adults Participants
Enrollment	158 participants
Start Date	2026-06-01
Primary Completion	2026-09-30 (estimated)
Study Completion	2026-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-01